ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 314,42
-0,56%
Dow Jones
42 299,70
-1,61%
DAX
19 909,14
-0,25%
Brent Oil
74,245
0,84%
Bitcoin
91 370,10
-2,30%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE

  6. Emergent Biosolutions Inc (EBS) Cours

Emergent Biosolutions Inc

Emergent Biosolutions Inc (EBS)

NYSE
9,21
0,94
( 11,37% )
Mis à jour : 16:08:58
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
9,21
Prix Achat
-
Prix Vente
-
Volume échangé
336 335
8,26 Fourchette du Jour 9,21
1,42 Plage de 52 semaines 15,10
Cap du marché
499,036M
Clôture Veille
8,27
Ouverture
8,28
Dernière Transaction
39
@
9.24
Dernière heure de transaction
16:09:02
Volume financier
US$ 2 862 806
VWAP
8,5118
Volume moyen (3 m)
1 246 136
Actions en circulation
54 184 186
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,62
Bénéfice par action (BPA)
-14,04
Chiffre d'affairess
1,05B
Bénéfice net
-760,5M

À propos de Emergent Biosolutions Inc

Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based... Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.emergentbiosolutions.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Emergent Biosolutions Inc est coté dans le secteur Pharmaceutical Preparations de la New York Stock Exchange avec le ticker EBS. Le dernier cours de clôture d'Emergent Biosolutions était de US$8,27. Au cours de la dernière année, les actions de Emergent Biosolutions ont été négociées dans une fourchette de prix de US$ 1,42 à US$ 15,10.

Emergent Biosolutions compte actuellement 54 184 186 actions en circulation. La capitalisation boursière d'Emergent Biosolutions est de US$448,10 million. Emergent Biosolutions a un ratio cours/bénéfice (ratio PE) de -0.62.

EBS Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

17 Décembre 2024
Edgar (US Regulatory)

Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

GAITHERSBURG, Md., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the...

16 Décembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

10 Décembre 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

05 Décembre 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

04 Décembre 2024
Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

02 Décembre 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

21 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

14 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
11.1414.1263940528.079.28667.837424488.26939403CS
4-0.85-8.4493041749510.0610.17.829808858.63725871CS
120.090.9868421052639.1212.737.7112461369.31226543CS
262.3834.84626647146.8315.15.2522001499.24818533CS
526.86291.9148936172.3515.11.4230884105.54791537CS
156-36.39-79.802631578945.652.771.4218352179.02032919CS
260-44.89-82.975970425154.1137.611.42136665522.14638451CS

EBS - Frequently Asked Questions (FAQ)

What is the current Emergent Biosolutions share price?
The current share price of Emergent Biosolutions is US$ 9,21
How many Emergent Biosolutions shares are in issue?
Emergent Biosolutions has 54 184 186 shares in issue
What is the market cap of Emergent Biosolutions?
The market capitalisation of Emergent Biosolutions is USD 448,1M
What is the 1 year trading range for Emergent Biosolutions share price?
Emergent Biosolutions has traded in the range of US$ 1,42 to US$ 15,10 during the past year
What is the PE ratio of Emergent Biosolutions?
The price to earnings ratio of Emergent Biosolutions is -0,62
What is the cash to sales ratio of Emergent Biosolutions?
The cash to sales ratio of Emergent Biosolutions is 0,45
What is the reporting currency for Emergent Biosolutions?
Emergent Biosolutions reports financial results in USD
What is the latest annual turnover for Emergent Biosolutions?
The latest annual turnover of Emergent Biosolutions is USD 1,05B
What is the latest annual profit for Emergent Biosolutions?
The latest annual profit of Emergent Biosolutions is USD -760,5M
What is the registered address of Emergent Biosolutions?
The registered address for Emergent Biosolutions is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Emergent Biosolutions website address?
The website address for Emergent Biosolutions is www.emergentbiosolutions.com
Which industry sector does Emergent Biosolutions operate in?
Emergent Biosolutions operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
KOREKORE Group Holdings Inc
US$ 3,76
(54,10%)
3,68M
STEMStem Inc
US$ 0,7684
(29,23%)
30,07M
PERFPerfect Corp
US$ 2,9401
(15,30%)
280,12k
VNCEVince Holding Corp
US$ 4,561
(13,46%)
421,15k
SRFMSurf Air Mobility Inc
US$ 6,14
(9,45%)
276,25k
EVTLVertical Aerospace Ltd
US$ 11,83
(-23,68%)
203,7k
SESSES AI Corporation
US$ 2,0908
(-12,52%)
19,85M
MPLNChurchill Capital Corp III
US$ 15,41
(-12,04%)
41,28k
QBTSD Wave Quantum Inc
US$ 8,7865
(-11,34%)
18,04M
ACHRArcher Aviation Inc
US$ 9,98
(-10,73%)
11,25M
STEMStem Inc
US$ 0,7684
(29,23%)
30,07M
SESSES AI Corporation
US$ 2,0908
(-12,52%)
20,85M
QBTSD Wave Quantum Inc
US$ 8,7865
(-11,34%)
20,05M
BBAIBigBear ai Holdings Inc
US$ 4,195
(-0,36%)
14,59M
ACHRArcher Aviation Inc
US$ 9,98
(-10,73%)
12,43M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NYSE
EBS
Emergent Biosolutions
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés